Literature DB >> 8711047

Chronic psychiatric patients' use of caffeine: pharmacological effects and mechanisms.

A Kruger1.   

Abstract

The uses and effects of caffeine as a psychoactive drug in chronic psychiatric inpatient groups are described. Caffeine use and abuse is linked etiologically to diverse psychiatric disorders; its mechanisms of action are examined in relation to anxiety, anxiety neuroses, psychosis, schizophrenia, and caffeine intoxication and dependence. It is postulated that deleterious effects may result from the interaction of caffeine with commonly prescribed psychotropic drugs. A possible model of caffeine abuse is discussed. Increased public education about potential health problems related to caffeine consumption is suggested, and further controls of caffeine in psychiatric settings are recommended.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8711047     DOI: 10.2466/pr0.1996.78.3.915

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  4 in total

Review 1.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

2.  Potential link between caffeine consumption and pediatric depression: A case-control study.

Authors:  Cássia R Benko; Antonio C Farias; Lucilene G Farias; Erico F Pereira; Fernando M Louzada; Mara L Cordeiro
Journal:  BMC Pediatr       Date:  2011-08-25       Impact factor: 2.125

3.  Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.

Authors:  Alex Yartsev; Carmelle Peisah
Journal:  BMC Psychiatry       Date:  2021-04-13       Impact factor: 3.630

4.  Alteration of Resting Electroencephalography by Acute Caffeine Consumption in Early Phase Psychosis.

Authors:  Jenna N Bissonnette; T-Jay Anderson; Katelyn J McKearney; Philip G Tibbo; Derek J Fisher
Journal:  Clin EEG Neurosci       Date:  2021-11-22       Impact factor: 2.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.